Pdgfrb-Cre mice availableListed By : Volkhard Lindner
Maine Medical Center
CategoryGenePathwayDiseaseMember Organization
Transgenic/KO animalsAngiogenesisCardiovascularNAVBO
These mice are available on a collaborative basis following execution of a simple MTA:

Genesis. 2011 May 9. doi: 10.1002/dvg.20769. [Epub ahead of print]
Characterization of pdgfrb-cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries.
Cuttler AS, Leclair RJ, Stohn JP, Wang Q, Sorenson CM, Liaw L, Lindner V.
Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074.
With the intention to modulate gene expression in vascular mural cells of remodeling vessels, we generated and characterized transgenic mouse lines with Cre recombinase under the control of the platelet-derived growth factor receptor-ß promoter, referred to as Tg(Pdgfrb-Cre)(35Vli) . Transgenic mice were crossed with the Gt(ROSA)26Sor(tm1Sor) strain and examined for Cre activation by ß-galactosidase activity, which was compared with endogenous Pdgfrb expression. In addition, Pdgfrb-Cre mice were used to drive expression of a conditional myc-tagged Cthrc1 transgene. There was good overlap of ß-galactosidase activity with endogenous Pdgfrb immunoreactivity. However, dedifferentiation of vascular mural cells induced by carotid artery ligation revealed a dramatic discrepancy between ROSA26 reporter activity and Pdgfrb promoter driven Cre dependent myc-tagged Cthrc1 transgene expression. Our studies demonstrate the capability of the Pdgfrb-Cre mouse to drive conditional transgene expression as a result of prior Cre mediated recombination in tissues known to express endogenous Pdgfrb. In addition, the study shows that ROSA26 promoter driven reporter mice are not suitable for lineage marking of smooth muscle in remodeling blood vessels. © 2011 Wiley-Liss, Inc.

Copyright © 2011 Wiley-Liss, Inc.

PMID: 21557454 [PubMed - as supplied by publisher]
Send Peer RequestContact NAVBO ResearcherTell a Friend

Discuss this listingLast PostMessages
Enter discussion[no posts yet]0
Copyright © 2008-2018 ResearchAccelerator.org, all rights reserved